The deal comes just days after the US company’s shares debuted following its initial public offering (IPO), which raised HK$2.28…
Read More »Insilico Medicine
“Biotechnology is a high-risk field like a ‘molecular casino’,” said founder Alex Zhavoronkov. “Even with artificial intelligence, you can lose…
Read More »
More companies are making plans to raise funds from first-time stock offerings in Hong Kong, including those from the US,…
Read More »